Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older

NCT01954251 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

829

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

BIOLOGICAL: Herpes Zoster vaccine GSK 1437173A
BIOLOGICAL: GSK Biologicals' quadrivalent seasonal influenza vaccine FLU-D-QIV GSK2321138A

Sponsor

GlaxoSmithKline